Live Breaking News & Updates on Calliditas Tel

Stay updated with breaking news from Calliditas tel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

STADA and Calliditas announce the filing for full marketing authorization of Kinpeygo® in the EU

BAD VILBEL, Germany and STOCKHOLM, Sept. 28, 2023 /PRNewswire/ Partners STADA and Calliditas Therapeutics. ....

Bad Vilbel , European Medicines Agency , Committee For Medicinal Products Human Use , Calliditas Therapeutics , Nasdaq Stockholm , Medicinal Products , Human Use , Investor Relations , Calliditas Tel , Creditor Relationsstadastrasse ,

Calliditas - Year-End Report, 2022 (2)

"2022 was a fantastic year for Calliditas as we launched TARPEYO® in the US, the first approved drug for IgA. ....

United States , United Kingdom , Marie Galay , Kidney International , Viatris Pharmaceuticals Japan , Viatris Pharmaceuticals Japan Inc , European Commission , European Commission For Kinpeygo , Exchange Commission , American Society Of Nephrology , National Medical Products Administration , European Union Member States , American Society , Kidney Week , Everest Medicines , New Drug Application , Priority Review , China Everest Medicine , Events After , Reporting Period , Conditional Marketing Authorization , European Economic Area , Presentation February , Calliditas Tel , Nasdaq Stockholm , American Depositary Shares ,

Calliditas - Year-End Report, 2022 (1)

"2022 was a fantastic year for Calliditas as we launched TARPEYO® in the US, the first approved drug for IgA. ....

United States , United Kingdom , Marie Galay , Kidney International , Viatris Pharmaceuticals Japan , Viatris Pharmaceuticals Japan Inc , European Commission , European Commission For Kinpeygo , Exchange Commission , American Society Of Nephrology , National Medical Products Administration , European Union Member States , American Society , Kidney Week , Everest Medicines , New Drug Application , Priority Review , China Everest Medicine , Events After , Reporting Period , Conditional Marketing Authorization , European Economic Area , Presentation February , Calliditas Tel , Nasdaq Stockholm , American Depositary Shares ,

Calliditas to host fireside chat with its China commercial partner, Everest Medicines

STOCKHOLM, Dec. 9, 2022 /PRNewswire/ Calliditas Therapeutics AB (publ) ("Calliditas") today announced. ....

United States , Rogers Yongqing Luo , Marie Galay , Zhengying Zhu , National Medical Products Administration , European Commission , European Union Member States , Everest Medicines , Eastern Time , Central European Time , China Standard Time , Chief Medical Officer , Internal Medicine , Greater China , South Korea , New Drug Application , Calliditas Tel , Nasdaq Stockholm , American Depositary Shares , Nasdaq Global Select Market ,